Heart TransplantationHeartGraft RejectionHeart RateKidney TransplantationImmunosuppressive AgentsGraft SurvivalHeart FailureTransplantation, HomologousTransplantation, HeterotopicTransplantationTissue DonorsHeart DiseasesTime FactorsHeart-Assist DevicesCyclosporineWaiting ListsTransplantsPostoperative ComplicationsTreatment OutcomeLung TransplantationTissue and Organ ProcurementHeart-Lung TransplantationRetrospective StudiesCardiomyopathy, DilatedHeart Defects, CongenitalImmunosuppressionTacrolimusFollow-Up StudiesCytomegalovirus InfectionsHeart, ArtificialMyocardiumBiopsyRisk FactorsMycophenolic AcidProspective StudiesImmunocompromised HostHistocompatibility TestingPostoperative PeriodTransplantation ImmunologyHistocompatibilitySurvival RateFetal HeartCardiomyopathiesCod Liver OilCoronary DiseaseIsoantibodiesHemodynamicsExercise TestWater-Electrolyte ImbalanceVentricular Function, LeftSurvival AnalysisDrug SubstitutionTransplantation ToleranceGanciclovirBone Marrow TransplantationHeart ValvesCardiac CatheterizationKaplan-Meier EstimatePostpericardiotomy SyndromeCytomegalovirusHLA AntigensEndocardiumCyclosporinsCohort StudiesHeart AtriaIncidenceAlternariosisOxygen ConsumptionRisk AssessmentAcute DiseaseTransplantation, IsogeneicInvasive Pulmonary AspergillosisPrognosisEchocardiographyOpportunistic InfectionsMycobacterium haemophilumLiving DonorsCardiac Output, LowRats, Inbred LewStroke VolumeSirolimusBiological MarkersAnastomosis, SurgicalVentricular Dysfunction, LeftOrgan TransplantationAzathioprineCoronary VesselsDonor SelectionMyocardial IschemiaHematopoietic Stem Cell TransplantationChronic DiseaseFatal OutcomeLymphoproliferative DisordersUnited StatesTrichosporonosisKidneyHeart BlockProportional Hazards ModelsPredictive Value of Tests